(Q59305671)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18327678%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

title

Basiliximab induction therapy for live donor kidney transplantation: a long-term follow-up of prospective randomized controlled study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18327678%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

main subject

kidney transplantation

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18327678%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Mahmoud k

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18327678%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

author name string

Hussein A Sheashaa

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18327678%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Amani M Ismail

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18327678%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Mohamed A Sobh

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18327678%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Mohamed A Ghoneim

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18327678%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

publication date

11 March 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18327678%20AND%20SRC:MED&resulttype=core&format=json

Clinical and experimental nephrology

3 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18327678%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18327678%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18327678%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

page(s)

376-381

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18327678%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10157-008-0044-7

3 January 2020

exact match

0 references

cites work

A randomized, double-blinded comparison of Thymoglobulin versus Atgam for induction immunosuppressive therapy in adult renal transplant recipients

1 reference

12 December 2020

Reduction of acute renal allograft rejection by daclizumab. Daclizumab Double Therapy Study Group

1 reference

12 December 2020

A randomized prospective trial of prophylactic immunosuppression with ATG-fresenius versus OKT3 after renal transplantation.

1 reference

12 December 2020

1 reference

12 December 2020

Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group

1 reference

12 December 2020

Use of basiliximab and daclizumab in kidney transplantation

1 reference

12 December 2020

Basiliximab significantly reduces acute rejection in renal transplant patients given triple therapy with azathioprine

1 reference

12 December 2020

Single-bolus high-dose ATG for prophylaxis of rejection in renal transplantation--a prospective, randomized study

1 reference

12 December 2020

Long-term evaluation of basiliximab induction therapy in live donor kidney transplantation: a five-year prospective randomized study

1 reference

12 December 2020

Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group

1 reference

12 December 2020

Simulect (basiliximab) reduces acute cellular rejection in renal allografts from cadaveric and living donors

1 reference

12 December 2020

A prospective, randomized, multicenter trial of tacrolimus-based therapy with or without basiliximab in pediatric renal transplantation

1 reference

12 December 2020

The Banff 97 working classification of renal allograft pathology

1 reference

12 December 2020

Interleukin 2 receptor antagonists for renal transplant recipients: a meta-analysis of randomized trials

1 reference

12 December 2020

A multicenter, open-label, pharmacokinetic/pharmacodynamic safety, and tolerability study of basiliximab (Simulect) in pediatric de novo renal transplant recipients

1 reference

12 December 2020

Anti-interleukin-2 receptor monoclonal antibodies in renal transplantation

1 reference

12 December 2020

Basiliximab versus antithymocyte globulin for prevention of acute renal allograft rejection

1 reference

12 December 2020

Basiliximab reduces the incidence of acute cellular rejection in live-related-donor kidney transplantation: a three-year prospective randomized trial.

1 reference

12 December 2020

Rapid DNA typing of class II HLA antigens using the polymerase chain reaction and reverse dot blot hybridization

1 reference

12 December 2020

10.1007/S10157-008-0044-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18327678%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference